Rochester, MN3 Active Studies

Retinitis Pigmentosa Clinical Trials in Rochester, MN

Find 3 actively recruiting retinitis pigmentosa clinical trials in Rochester, MN. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
968
Enrolling

Recruiting Retinitis Pigmentosa Studies in Rochester

About Retinitis Pigmentosa Clinical Trials in Rochester

Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.

There are currently 3 retinitis pigmentosa clinical trials recruiting participants in Rochester, MN. These studies are seeking a combined 968 participants. Research is being sponsored by Columbia University, Crinetics Pharmaceuticals Inc., Solid Biosciences Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Retinitis Pigmentosa Clinical Trials in Rochester — FAQ

Are there retinitis pigmentosa clinical trials in Rochester?

Yes, there are 3 retinitis pigmentosa clinical trials currently recruiting in Rochester, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What retinitis pigmentosa treatments are being tested?

The 3 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.

Data updated October 12, 2026 from ClinicalTrials.gov